Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Catalyst Pharmaceuticals (CPRX) agrees $4.1bn buyout as Angelini Pharma plans to enter US rare disease market Angelini Pharma will pay $4.1 billion for Catalyst Pharmaceuticals at $31.50 a share, but CPRX closed at $31.10. The premium sits in the strategy, not the price. bySrinathMay 8, 2026